Vonicog Alfa 相關新聞

← 返回新聞總覽


Vonicog Alfa 目前有 0 則相關新聞報導,預測適應症 20 個。

本頁整合 Vonicog Alfa 的 AI 預測適應症與最新健康新聞,橘色標示的適應症表示近期有相關新聞報導。
藥物資訊
  • 原適應症:Prevention and treatment of haemorrhage or surgical bleeding in adults (age 18 years and older) with von Willebrand disease (VWD), when desmopressin (DDAVP) treatment alone is ineffective or...
  • 證據等級:L5
  • 預測適應症(20 個):
    • primary release disorder of platelets(100.0%)
    • Glanzmann thrombasthenia(100.0%)
    • pseudo-von Willebrand disease(100.0%)
    • hemophilia(100.0%)
    • Scott syndrome(100.0%)
    • acquired coagulation factor deficiency(99.9%)
    • Von Willebrand disease, X-linked form(99.9%)
    • bleeding diathesis due to a collagen receptor defect(99.9%)
    • hemorrhagic disorder due to a constitutional thrombocytopenia(99.9%)
    • flood factor deficiency(99.9%)
    • hereditary thrombocytosis with transverse limb defect(99.9%)
    • familial thrombomodulin anomalies(99.9%)
    • von Willebrand disease(99.8%)
    • inherited thrombophilia(99.8%)
    • small bowel Crohn disease(99.8%)
    • methylcobalamin deficiency type cblG(99.8%)
    • esophageal ulcer(99.8%)
    • gastritis(99.7%)
    • thrombotic thrombocytopenic purpura(99.7%)
    • hemorrhagic disorder due to a coagulation factors defect(99.6%)

查看完整藥物報告 →

相關新聞(0 則)

目前沒有相關新聞報導。當有新聞提到此藥物時,系統會自動收集並顯示在這裡。

免責聲明:本頁新聞由系統自動收集,僅供研究參考,不構成醫療建議。

Copyright © 2026 EuTxGNN Project. For research purposes only. Not medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.